231 related articles for article (PubMed ID: 9809899)
1. Long-term antithrombotic treatment for atrial fibrillation.
Nademanee K; Kosar EM
Am J Cardiol; 1998 Oct; 82(8A):37N-42N. PubMed ID: 9809899
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
[TBL] [Abstract][Full Text] [Related]
3. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
[TBL] [Abstract][Full Text] [Related]
4. [Frontiers in prevention of thromboembolism in nonvalvular atrial fibrillation].
Fukunami M
J Cardiol; 1999 Mar; 33 Suppl 1():65-70. PubMed ID: 10342139
[TBL] [Abstract][Full Text] [Related]
5. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
[TBL] [Abstract][Full Text] [Related]
6. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Singer DE; Albers GW; Dalen JE; Fang MC; Go AS; Halperin JL; Lip GYH; Manning WJ
Chest; 2008 Jun; 133(6 Suppl):546S-592S. PubMed ID: 18574273
[TBL] [Abstract][Full Text] [Related]
8. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
9. Lessons from the Stroke Prevention in Atrial Fibrillation trials.
Hart RG; Halperin JL; Pearce LA; Anderson DC; Kronmal RA; McBride R; Nasco E; Sherman DG; Talbert RL; Marler JR;
Ann Intern Med; 2003 May; 138(10):831-8. PubMed ID: 12755555
[TBL] [Abstract][Full Text] [Related]
10. [Atrial fibrillation: embolic risk and prevention].
Rossi P
Cardiologia; 1993 Dec; 38(12 Suppl 1):319-25. PubMed ID: 8020031
[TBL] [Abstract][Full Text] [Related]
11. Prevention of thromboembolic events in atrial fibrillation.
Koefoed BG; Gulløv AL; Petersen P
Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
[TBL] [Abstract][Full Text] [Related]
12. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
Yasaka M; Yamaguchi T
CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
[TBL] [Abstract][Full Text] [Related]
13. Role of anticoagulant therapy in atrial fibrillation.
Kottkamp H; Hindricks G; Breithardt G
J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S86-96. PubMed ID: 9727682
[TBL] [Abstract][Full Text] [Related]
14. Preventing stroke in patients with nonrheumatic atrial fibrillation.
Nelson KM; Talbert RL
Am J Hosp Pharm; 1994 May; 51(9):1175-83. PubMed ID: 8042636
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation, anticoagulation, and stroke.
Morley J; Marinchak R; Rials SJ; Kowey P
Am J Cardiol; 1996 Jan; 77(3):38A-44A. PubMed ID: 8607390
[TBL] [Abstract][Full Text] [Related]
16. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
17. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.
Man-Son-Hing M; Laupacis A; O'Connor AM; Biggs J; Drake E; Yetisir E; Hart RG
JAMA; 1999 Aug; 282(8):737-43. PubMed ID: 10463708
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.
Hart RG; Pearce LA; McBride R; Rothbart RM; Asinger RW
Stroke; 1999 Jun; 30(6):1223-9. PubMed ID: 10356104
[TBL] [Abstract][Full Text] [Related]
19. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
[TBL] [Abstract][Full Text] [Related]
20. ABC of atrial fibrillation. Antithrombotic treatment for atrial fibrillation.
Lip GY; Lowe GD
BMJ; 1996 Jan; 312(7022):45-9. PubMed ID: 8555864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
